| Advances and highlights in asthma in 2021 I Agache, I Eguiluz‐Gracia, C Cojanu, A Laculiceanu, S Del Giacco, ... Allergy 76 (11), 3390-3407, 2021 | 110 | 2021 |
| Influence of cyclophosphamide and its metabolic products on the activity of peritoneal macrophages in mice K Bryniarski, M Szczepanik, M Ptak, M Zemelka, W Ptak Pharmacological Reports 61 (3), 550-557, 2009 | 61 | 2009 |
| Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper M Jutel, I Agache, M Zemelka‐Wiacek, M Akdis, T Chivato, S Del Giacco, ... Allergy 78 (11), 2851-2874, 2023 | 46 | 2023 |
| Influence of melatonin and its precursor L-tryptophan on Th1 dependent contact hypersensitivity M Majewska, K Zajac, M Zemelka, M Szczepanik J. Physiol. Pharmacol 58 (Suppl 6), 125-132, 2007 | 33 | 2007 |
| Epicutaneous immunization with myelin basic protein protects from the experimental autoimmune encephalomyelitis M Majewska, K Zajac, Z Srebro, P Sura, L Ksiazek, M Zemelka, ... Pharmacological reports 59 (1), 74, 2007 | 32 | 2007 |
| Epicutaneous immunization with protein antigen TNP-Ig alleviates TNBS-induced colitis in mice M Majewska-Szczepanik, M Góralska, K Marcińska, M Zemelka-Wiącek, ... Pharmacological Reports 64 (6), 1497-1504, 2012 | 27 | 2012 |
| Epicutaneous immunization with DNP‐BSA induces CD4+ CD25+ Treg cells that inhibit Tc1‐mediated CS M Majewska‐Szczepanik, M Zemelka‐Wiącek, W Ptak, L Wen, ... Immunology and cell biology 90 (8), 784-795, 2012 | 27 | 2012 |
| EAACI guidelines on environmental science in allergic diseases and asthma–leveraging artificial intelligence and machine learning to develop a causality model in exposomics MH Shamji, M Ollert, IM Adcock, O Bennett, A Favaro, R Sarama, ... Allergy 78 (7), 1742-1757, 2023 | 23 | 2023 |
| Complementary methods for contact hypersensitivity (CHS) evaluation in mice M Zemelka-Wiącek, M Majewska-Szczepanik, W Pyrczak, M Szczepanik Journal of immunological methods 387 (1-2), 270-275, 2013 | 20 | 2013 |
| COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations M Jutel, MJ Torres, O Palomares, CA Akdis, T Eiwegger, E Untersmayr, ... Allergy 77 (8), 2313-2336, 2022 | 18 | 2022 |
| Epicutaneous immunization with protein antigen induces antigen-non-specific suppression of CD8 T cell mediated contact sensitivity M Zemelka-Wiącek, M Majewska-Szczepanik, W Ptak, M Szczepanik Pharmacological Reports 64 (6), 1485-1496, 2012 | 13 | 2012 |
| Immunotherapy: state-of-the-art review of therapies and theratypes I Agache, M Zemelka-Wiącek, MH Shamji, M Jutel Journal of Allergy and Clinical Immunology 150 (6), 1279-1288, 2022 | 12 | 2022 |
| The One Health approach for allergic diseases and asthma M Jutel, GS Mosnaim, JA Bernstein, S Del Giacco, DA Khan, KC Nadeau, ... Allergy 78 (7), 1777-1793, 2023 | 10 | 2023 |
| Validated allergen exposure chamber is plausible tool for the assessment of house dust mite‐triggered allergic rhinitis M Zemelka‐Wiacek, A Kosowska, E Winiarska, E Sobanska, M Jutel Allergy 78 (1), 168-177, 2023 | 9 | 2023 |
| Role of TLR ligands in epicutaneously induced contrasuppression M Majewska, K Bryniarski, M Ptak, K Zając, M Zemelka, FM Lobo, W Ptak, ... Pharmacological Reports 61 (3), 539-549, 2009 | 9 | 2009 |
| Hot topics in allergen immunotherapy, 2023: current status and future perspective M Zemelka‐Wiacek, I Agache, CA Akdis, M Akdis, TB Casale, S Dramburg, ... Allergy 79 (4), 823-842, 2024 | 7 | 2024 |
| The potential impact of nano-and microplastics on human health: Understanding human health risks. E Winiarska, M Jutel, M Zemelka-Wiacek Environmental Research, 118535, 2024 | 7 | 2024 |
| The artificial intelligence (AI) revolution: How important for scientific work and its reliable sharing M Jutel, M Zemelka‐Wiacek, M Ordak, O Pfaar, T Eiwegger, ... Allergy 78 (8), 2085-2088, 2023 | 7 | 2023 |
| Epicutaneous immunization with protein antigen protects from collagen induced arthritis F Lobo, K Zajac, M Majewska, M Zemelka, M Szczepanik JOURNAL OF IMMUNOLOGY 176, S246-S246, 2006 | 7 | 2006 |
| The Clinical and Immunological Activity Depending on the Presence of Interferon γ in Primary Sjögren’s Syndrome—A Pilot Study A Sebastian, M Madej, M Sebastian, A Łuczak, P Gajdanowicz, ... Journal of clinical medicine 11 (1), 3, 2021 | 5 | 2021 |
